Qingdao Haier Biomedical Co Ltd (688139) - Total Liabilities

Latest as of March 2026: CN¥1.15 Billion CNY ≈ $168.81 Million USD

Based on the latest financial reports, Qingdao Haier Biomedical Co Ltd (688139) has total liabilities worth CN¥1.15 Billion CNY (≈ $168.81 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Qingdao Haier Biomedical Co Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Qingdao Haier Biomedical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Qingdao Haier Biomedical Co Ltd to evaluate short-term liquidity relative to the company's equity base.

Qingdao Haier Biomedical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Qingdao Haier Biomedical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Guizhou Qianyuan Power Co Ltd SHE:002039	China	CN¥8.60 Billion
Jiangxi Guotai Civilian SHG:603977	China	CN¥2.43 Billion
Playtika Holding Corp NASDAQ:PLTK	USA	$3.76 Billion
Everi Holdings Inc NYSE:EVRI	USA	$1.94 Billion
Jiangsu Bojun Industrial Technology Co. Ltd SHE:300926	China	CN¥4.96 Billion
Zhejiang Chunhui Intelligent Control Co. Ltd. SHE:300943	China	CN¥248.56 Million
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	China	CN¥82.76 Million
CSG Holding Co Ltd SHE:000012	China	CN¥18.25 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Qingdao Haier Biomedical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Qingdao Haier Biomedical Co Ltd market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.57	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.26	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.20	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Qingdao Haier Biomedical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Qingdao Haier Biomedical Co Ltd (2016–2025)

The table below shows the annual total liabilities of Qingdao Haier Biomedical Co Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.17 Billion ≈ $170.96 Million	-0.09%
2024-12-31	CN¥1.17 Billion ≈ $171.11 Million	+7.70%
2023-12-31	CN¥1.09 Billion ≈ $158.87 Million	-19.02%
2022-12-31	CN¥1.34 Billion ≈ $196.18 Million	+6.31%
2021-12-31	CN¥1.26 Billion ≈ $184.54 Million	+8.89%
2020-12-31	CN¥1.16 Billion ≈ $169.46 Million	+99.30%
2019-12-31	CN¥581.08 Million ≈ $85.03 Million	-47.84%
2018-12-31	CN¥1.11 Billion ≈ $163.01 Million	+93.43%
2017-12-31	CN¥575.92 Million ≈ $84.28 Million	+154.31%
2016-12-31	CN¥226.46 Million ≈ $33.14 Million	--

About Qingdao Haier Biomedical Co Ltd

SHG:688139 China Medical Devices

Market Cap

$1.24 Billion

CN¥8.44 Billion CNY

Market Cap Rank

#8159 Global

#1964 in China

Share Price

CN¥26.67

Change (1 day)

-1.22%

52-Week Range

CN¥26.40 - CN¥37.36

All Time High

CN¥147.76